Insulin Glargine for Dysglycemia Protects Against Cognitive Impairment
Insulin glargine for dysglycemia was associated with a reduced cognitive impairment risk after a median follow-up of 6.2 years.
Source: psychiatryadvisor.com
Outcomes Reduction News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Outcomes Reduction. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Outcomes Reduction Today - Breaking & Trending Today
Insulin Glargine for Dysglycemia Protects Against Cognitive Impairment
Insulin glargine for dysglycemia was associated with a reduced cognitive impairment risk after a median follow-up of 6.2 years.
Source: neurologyadvisor.com
Insulin Glargine for Dysglycemia Protects Against Cognitive Impairment
Insulin glargine for dysglycemia was associated with a reduced cognitive impairment risk after a median follow-up of 6.2 years.
Source: endocrinologyadvisor.com